← board
ACUT
distress 2/10 · well-funded / low risk$0.18-12%today-92% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
—
Shares 1y
0%
Price & events
-72.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
-12.2%
1D
-1.9%
1W
-13.0%
1M
-43.7%
3M
-72.3%
6M
-82.2%
1Y
-53.8%
2Y
—
5Y
-91.0%
All
Overview
- Market Cap
- $2.89M
- Volume
- 827
- 52 Week Range
- $0.16 – $2.21
- Total Shares
- 16.07M
- Float Shares
- 11.43M
- % Held by Insiders
- 50.92%
- % Held by Institutions
- 0.00%
- RVOL
- 0.16x
- Beta
- 1.88
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 16,072,267 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.